Conference - Online
The new FDA Draft Guidance entitled “Contract Manufacturing Arrangements for Drugs: Quality Agreements” focuses on the documented and agreed upon responsibilities of the “Owner” and the “Contracted Facility”.A key component is the level of Quality Oversight from the Owner of the drug product before, during the contract negotiation and after the signed agreement is in place. ICH Q10 and other Quality Management guidance discusses the controls required over outsourced activities in general. Understanding that Contract Manufacturing and Testing services are extremely critical, the questions is – are these outsourced activities the only ones that require a formal Quality Agreement? There are other critical outsources activities that should have the same level of formality, communication and documentation requirements.
Organization: Global Compliance Trainings
For more information, please visit: http://www.globalcompliancetrainings.com/index.php?route=product/product&product_id=10&list=Miguel%20Montalvo
May 25, 2014 (10:00 AM - 01:00 PM)
201,N Squirrel road, Suite 1007, Auburn Hills, Michigan United States - 48326
Contact: John Gordan (webinar@globalcompliancetrainings.com)
Phone: 2482120588
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
